UPDATE: The Mullings Group Companies (TMG) has just announced a significant expansion in Israel, reaffirming its commitment to the nation’s burgeoning medtech ecosystem. This strategic move, revealed earlier today, aims to strengthen ties between Israeli innovations and global markets, driving immediate benefits for the industry.
With a history of over 20 years in Israel, TMG has been a pivotal player in connecting Israeli companies with opportunities in the U.S. market. The establishment of this enhanced presence is set to deepen relationships and provide essential daily support to both emerging and established medtech firms. “When an Israeli CEO is confident that their U.S. team is built from the very best, they gain the freedom to keep their center of gravity in Israel,” stated Joe Mullings, Chairman & CEO of TMG.
Leading this initiative is Ido Hadari, a seasoned executive with extensive experience in Israel’s healthcare sector. Hadari emphasized, “Israeli medtech and digital health founders have earned their place among the world’s most innovative leaders. The right leaders accelerate success; the wrong ones can cost years. That’s where TMG steps in.”
TMG’s increased footprint is set to kick off at the annual ICI Meeting happening from December 7-9, 2025, where key executives including Mullings, Hadari, and Tori Gould will be in attendance. This engagement underscores TMG’s dedication to fostering collaboration and advancing medtech innovation on a global scale.
The establishment of the U.S./Israel Medtech Delegation, of which TMG is a founding member, is a crucial part of this initiative. This delegation aims to facilitate awareness and access for Israeli technologies to international markets, marking a significant step in enhancing Israel’s standing in the global medtech arena.
TMG has successfully completed over 9,000 searches in the medtech sector, establishing a reputation as the “voice of the industry.” Their commitment to bringing top-tier executives to Israeli companies positions TMG as a vital conduit for success in the competitive U.S. market.
As TMG expands its operations, it aims to accelerate the commercial success of innovative technologies emerging from Israel, ultimately benefiting patients worldwide. This move is not just about business; it reflects TMG’s broader mission to empower Israeli companies and ensure they thrive on the global stage.
For those in the medtech industry, this expansion is a key development to watch. The impact of TMG’s initiatives is expected to resonate throughout the sector, creating new opportunities for collaboration and innovation. As the medtech landscape evolves, TMG’s expanded presence in Israel marks a pivotal moment for both the company and the industry at large.
Stay tuned for more updates as TMG continues to drive advancements in medtech and strengthen its connections within Israel and beyond.
